Literature DB >> 15980743

Mortality and morbidity after surgery of mid and low rectal cancer. Results of a French prospective multicentric study.

Arnaud Alves1, Yves Panis, Pierre Mathieu, Fabrice Kwiatkowski, Karem Slim, Georges Mantion.   

Abstract

BACKGROUND: The aim of the study was to assess both mortality and morbidity following resection of mid and low rectal cancers in a French prospective multicentric study. PATIENTS: From June to September 2002, consecutive patients undergoing resection for cancer of the mid- or lower rectum were prospectively included in a multicentric study. Both postoperative mortality and morbidity were recorded. Multivariate statistical analysis was performed in order to assess risk factors predictive of postoperative morbidity.
RESULTS: 238 patients with a mean age of 66 +/- 13 years (range: 26-88) were included. Neoadjuvant radiotherapy was performed in 68% of the patients. Total mesorectal excision was performed in 218 patients (92%), of whom 151 (63%) had a sphincter saving procedure. Six patients died (2.5%). Overall postoperative morbidity rate was 43%, including anastomotic leakage (11%) and reoperation (5%). Mean hospital-in-stay was 20 +/- 16 days (range: 3191). Four independent risk factors of morbidity were found: perioperative fecal contamination (OR = 3.9 [1.1; 13.5]), mean operating time longer than 6 hours (OR = 4.5 [1.7; 12.1]), ASA score > 2 (OR = 3.2 [1.6; 7.9]), and smocking (OR = 3.3 [1.2; 8.9]).
CONCLUSIONS: Resection of cancer involving the middle or lower rectum with sphincter saving procedures was possible in two-thirds of the patients and was associated with 2.5% mortality and 43% morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15980743     DOI: 10.1016/s0399-8320(05)82121-9

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  17 in total

1.  Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results.

Authors:  Jose M Ramirez; Vicente Aguilella; Javier Valencia; Javier Ortego; Jose A Gracia; Pilar Escudero; Ricardo Esco; Mariano Martinez
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  Predicting response to chemoradiotherapy in rectal and oesophageal cancer with 18F-FDG: prognostic value and possible role in patient management.

Authors:  Elif Hindié; Christophe Hennequin; Jean-luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10       Impact factor: 9.236

3.  30-day mortality after elective colorectal surgery can reasonably be predicted.

Authors:  A C Murray; C Mauro; J Rein; R P Kiran
Journal:  Tech Coloproctol       Date:  2016-07-15       Impact factor: 3.781

4.  TME quality in rectal cancer surgery.

Authors:  T Herzog; O Belyaev; A M Chromik; D Weyhe; C A Mueller; J Munding; A Tannapfel; W Uhl; Matthias H Seelig
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

5.  Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

Authors:  K Horisberger; R D Hofheinz; P Palma; A K Volkert; S Rothenhoefer; F Wenz; A Hochhaus; S Post; F Willeke
Journal:  Int J Colorectal Dis       Date:  2007-12-11       Impact factor: 2.571

6.  Stapled marsupialisation of chronic low rectal anastomotic sinuses.

Authors:  Olivier Brehant; Adina Hanes; David Fuks; Charles Sabbagh; Sébastien Blanpain; Franck Brazier; Jean-Marc Regimbeau
Journal:  Int J Colorectal Dis       Date:  2009-08-05       Impact factor: 2.571

7.  Are oncological long-term outcomes equal after laproscopic completed and converted laparoscopic converted rectal resection for cancer?

Authors:  M Finochi; B Menahem; G Lebreton; J Lubrano; Y Eid; A Alves
Journal:  Tech Coloproctol       Date:  2020-08-28       Impact factor: 3.781

Review 8.  Personalized surgical management of colorectal cancer in elderly population.

Authors:  Giampaolo Ugolini; Federico Ghignone; Davide Zattoni; Giacomo Veronese; Isacco Montroni
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

9.  Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications.

Authors:  Leif Schiffmann; Nicole Wedermann; Michael Gock; Friedrich Prall; Gunther Klautke; Rainer Fietkau; Bettina Rau; Ernst Klar
Journal:  BMC Surg       Date:  2013-09-30       Impact factor: 2.102

10.  Surgical site infections following short-term radiotherapy and total mesorectal excision: results of a randomized study examining the role of gentamicin collagen implant in rectal cancer surgery.

Authors:  A Rutkowski; L Zając; L Pietrzak; M Bednarczyk; A Byszek; J Oledzki; T Olesiński; M Szpakowski; P Saramak; M Chwalinski
Journal:  Tech Coloproctol       Date:  2014-07-04       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.